Degenerative Disc Disease Treatment Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Degenerative Disc Disease Treatment Market In 2029?
There has been a significant expansion in the market size for degenerative disc disease treatment in the past years. It is anticipated that the market will see an increase from $27.07 billion in 2024 to a substantial $29.01 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. This growth experienced in the historical period can be traced back to factors such as the increasing aging population, the rising prevalence of sedentary lifestyles, the surge in technological advancements in the medical field, heightened awareness, climbing obesity rates, escalating incidents of sports-related injuries, and the broadening access to healthcare services.
What Growth Rate Is Forecasted for the Degenerative Disc Disease Treatment Market by 2029?
It is anticipated that the market for degenerative disc disease treatment will witness robust growth in the coming years, expanding to $37.86 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.9%. The projected growth during this period can be traced back to factors such as increased spending on healthcare, a surging demand for minimally invasive procedures, improved patient education, growth in clinical research, and a spike in global spine disorder incidence rates. Key trends expected during this forecast period consist of the incorporation of AI and machine learning, the evolution of regenerative medicine, advancements in minimally invasive surgery, wearable technology, 3D printings for tailor-made implants, telemedicine and remote consultations, and an emphasis on individualized medicine.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp
Which Key Companies Are Shaping the Future of the Degenerative Disc Disease Treatment Market?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health
Which Factors Are Driving Demand in the Degenerative Disc Disease Treatment Industry?
The escalating occurrence of sports-related injuries is projected to stimulate the expansion of the degenerative disc disease treatment market. Sports injuries, which constitute physical harm or trauma often experienced by athletes or those participating in physical activities, typically arise from abrupt impacts, overuse, or incorrect techniques. The surge in sports injuries is frequently linked to aspects such as elevated participation levels, intensifying training routines, and an augmented stress on competitive performance. Treatments for degenerative disc disease are employed in sports injuries to control chronic back pain and reinstate function when disc decay interferes with an athlete’s performance and mobility. For example, in November 2023, the UK-based insurance intermediary firm, Howden Group Holdings Ltd, reported that injuries incurred in October 2022 resulted in athletes being out of action for an average of 11.35 days prior to tournaments. This duration extended to 19.41 days by January 2023. Consequently, the increasing sports injuries are fueling the growth of the degenerative disc disease treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=18784&type=smp
How Is the Degenerative Disc Disease Treatment Market Segmented by Several Divisions?
The degenerative disc disease treatment market covered in this report is segmented –
1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center
Subsegments:
1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Muscle Relaxants, Corticosteroids, Antidepressants
2) By Novel Therapies: Gene Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Biologic Agents, Regenerative Medicine, Cell-Based Therapies, Growth Factor Therapies
What are the Emerging Market Trends Driving the Growth of the Degenerative Disc Disease Treatment Industry?
Major players in the degenerative disc disease treatment field are honing their focus on creating innovative therapies like the injectable disc cell therapy (IDCT). This is done in an effort to enhance patient results through escalating disc volume, reducing lower back pain, and diminishing the reliance on pain medication. IDCT, a regenerative treatment, is designed to target lumbar degenerative disc disease with symptoms. In an illustration of this in action, DiscGenics Inc., a biopharmaceutical firm based in the US, was granted FDA approval for their advanced regenerative medicine treatment, the injectable disc cell therapy (IDCT), for symptomatic lumbar degenerative disc disease in February 2023. This groundbreaking therapy employs a live progenitor cell population, sourced from donated adult human intervertebral disc tissue. The potential of IDCT rests in its ability to boost disc volume, relieve lower back pain, and curtail the necessity for pain medication among affected patients.
Access The Full Report Here:
Which Regions Are Driving Growth in the Degenerative Disc Disease Treatment Market?
North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18784
This Report Delivers Insight On:
1. How big is the degenerative disc disease treatment market, and how is it changing globally?
2. Who are the major companies in the degenerative disc disease treatment market, and how are they performing?
3. What are the key opportunities and risks in the degenerative disc disease treatment market right now?
4. Which products or customer segments are growing the most in the degenerative disc disease treatment market?
5. What factors are helping or slowing down the growth of the degenerative disc disease treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
